Skip to Main Content

Author Details

Larissa A Pikor
Ottawa Hospital Research Institute
2010
32
24
PMIDPaper TitleJournal TitlePublished Year
36405739Oncolytic virus driven T-cell-based combination immunotherapy platform for colorectal cancer.Front Immunol2022
35393414Virally programmed extracellular vesicles sensitize cancer cells to oncolytic virus and small molecule therapy.Nat Commun2022
29367345Dimethyl fumarate potentiates oncolytic virotherapy through NF-κB inhibition.Sci Transl Med2018
29921327Enhanced susceptibility of cancer cells to oncolytic rhabdo-virotherapy by expression of Nodamura virus protein B2 as a suppressor of RNA interference.J Immunother Cancer2018
29507679Differentially expressed microRNAs in lung adenocarcinoma invert effects of copy number aberrations of prognostic genes.Oncotarget2018
27096814The role of epigenetics and long noncoding RNA MIAT in neuroendocrine prostate cancer.Epigenomics2016
26583808Macrophages, Inflammation, and Lung Cancer.Am J Respir Crit Care Med2016
27357447Developmental transcription factor NFIB is a putative target of oncofetal miRNAs and is associated with tumour aggressiveness in lung adenocarcinoma.J Pathol2016
26809501Integrated analysis of the prostate cancer small-nucleolar transcriptome reveals SNORA55 as a driver of prostate cancer progression.Mol Oncol2016
24596130Disruption of KEAP1/CUL3/RBX1 E3-ubiquitin ligase complex components by multiple genetic mechanisms: Association with poor prognosis in head and neck cancer.Head Neck2015
28741515Oncolytic Viruses: Exploiting Cancer's Deal with the Devil.Trends Cancer2015
25907283Microtubule affinity-regulating kinase 2 is associated with DNA damage response and cisplatin resistance in non-small cell lung cancer.Int J Cancer2015
26013764Unique somatic and malignant expression patterns implicate PIWI-interacting RNAs in cancer-type specific biology.Sci Rep2015
23318427SOX15 is a candidate tumor suppressor in pancreatic cancer with a potential role in Wnt/β-catenin signaling.Oncogene2014
25594027SOX15 and other SOX family members are important mediators of tumorigenesis in multiple cancer types.Oncoscience2014
25342220Smoking status impacts microRNA mediated prognosis and lung adenocarcinoma biology.BMC Cancer2014
25114896Unique pattern of component gene disruption in the NRF2 inhibitor KEAP1/CUL3/RBX1 E3-ubiquitin ligase complex in serous ovarian cancer.Biomed Res Int2014
24519926Identification of a long non-coding RNA as a novel biomarker and potential therapeutic target for metastatic prostate cancer.Oncotarget2014
23633034The detection and implication of genome instability in cancer.Cancer Metastasis Rev2013
24138990Frequent concerted genetic mechanisms disrupt multiple components of the NRF2 inhibitor KEAP1/CUL3/RBX1 E3-ubiquitin ligase complex in thyroid cancer.Mol Cancer2013
24170126YEATS4 is a novel oncogene amplified in non-small cell lung cancer that regulates the p53 pathway.Cancer Res2013
23942079Mutational analysis of Polycomb genes in solid tumours identifies PHC3 amplification as a possible cancer-driving genetic alteration.Br J Cancer2013
24011633Genetic alterations defining NSCLC subtypes and their therapeutic implications.Lung Cancer2013
22427650Calpain 2 regulates Akt-FoxO-p27(Kip1) protein signaling pathway in mammary carcinoma.J Biol Chem2012
22852089Mechanistic Roles of Noncoding RNAs in Lung Cancer Biology and Their Clinical Implications.Genet Res Int2012
22629454Divergent genomic and epigenomic landscapes of lung cancer subtypes underscore the selection of different oncogenic pathways during tumor development.PLoS One2012
22328562Integrative genomics identified RFC3 as an amplified candidate oncogene in esophageal adenocarcinoma.Clin Cancer Res2012
21490570DNA extraction from paraffin embedded material for genetic and epigenetic analyses.J Vis Exp2011
21795997Genetic disruption of KEAP1/CUL3 E3 ubiquitin ligase complex components is a key mechanism of NF-kappaB pathway activation in lung cancer.J Thorac Oncol2011
21541180MicroRNA gene dosage alterations and drug response in lung cancer.J Biomed Biotechnol2011
20020444Methylation analysis by DNA immunoprecipitation.J Cell Physiol2010
20682026A sequence-based approach to identify reference genes for gene expression analysis.BMC Med Genomics2010
  • 1 - 32 of 32

Recommended Authors

Career Start Year 2015
Number of shared co-authors 1
University of Trento
Career Start Year 2012
Number of shared co-authors 0
German Cancer Research Center
Career Start Year 2010
Number of shared co-authors 2
The Netherlands Cancer Institute
Career Start Year 2008
Number of shared co-authors 0
University of Basel
Career Start Year 2008
Number of shared co-authors 1
Montefiore Medical Center
Career Start Year 2008
Number of shared co-authors 3
Quantitative Biomedical Research Center
Career Start Year 2007
Number of shared co-authors 2
Greehey Children's Cancer Research Institute
Career Start Year 2007
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 0
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year 2005
Number of shared co-authors 0
Uniformed Services University of the Health Sciences
Career Start Year 2004
Number of shared co-authors 0
University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 2
Roswell Park Comprehensive Cancer Center
Career Start Year 2003
Number of shared co-authors 0
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 1
The Wistar Institute
Career Start Year 2003
Number of shared co-authors 0
Fox Chase Cancer Center
Career Start Year 2002
Number of shared co-authors 0
University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center
Career Start Year 2001
Number of shared co-authors 1
Monash University
Career Start Year 2000
Number of shared co-authors 3
Institute for Translational Epigenetics, University of Cologne
Career Start Year 1999
Number of shared co-authors 0
Michigan Center for Translational Pathology.
Career Start Year 1999
Number of shared co-authors 2
Center for Cancer Research, University of Tennessee Health Science Center
Career Start Year 1999
Number of shared co-authors 2
Janssen Research and Development LLC
Career Start Year 1997
Number of shared co-authors 5
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1997
Number of shared co-authors 4
Novartis Institutes for BioMedical Research
Career Start Year 1996
Number of shared co-authors 1
Kurume University School of Medicine
Career Start Year 1993
Number of shared co-authors 1
University of Michigan Medical School.
Career Start Year 1993
Number of shared co-authors 8
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 0
Stanford University School of Medicine
Career Start Year 1987
Number of shared co-authors 2
Broad Institute
Career Start Year 1983
Number of shared co-authors 6

Collaborators

British Columbia Cancer Research Institute
Co-authored papers 26
The National Institutes of Health
Co-authored papers 6
University Health Network, University of Toronto
Co-authored papers 6
Ottawa Hospital Research Institute
Co-authored papers 5
Ottawa Hospital Research Institute, University of Ottawa
Co-authored papers 4
Ottawa Hospital Research Institute
Co-authored papers 4
University of British Columbia
Co-authored papers 3
Cancer Research Institute, Queen's University
Co-authored papers 3
University of Ottawa
Co-authored papers 3
Schroeder Arthritis Institute
Co-authored papers 3
Agricultural Genomics Institute at Shenzhen, Chinese Academy of Agricultural Sciences
Co-authored papers 3
University of British Columbia
Co-authored papers 2
Ottawa Hospital Research Institute
Co-authored papers 2
Ottawa Hospital Research Institute
Co-authored papers 2
Ottawa Hospital Research Institute, University of Ottawa
Co-authored papers 2
Ottawa Hospital Research Institute
Co-authored papers 2
Fujian Medical University Cancer Hospital and Fujian Cancer Hospital
Co-authored papers 2
The Ottawa Hospital Research Institute
Co-authored papers 2
University of British Columbia
Co-authored papers 2
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 2
The Ottawa Hospital/University of Ottawa
Co-authored papers 2
Co-authored papers 2
Ottawa Hospital Research Institute
Co-authored papers 2
University of Ottawa Heart Institute
Co-authored papers 1
University of British Columbia
Co-authored papers 1
The Institute of Cancer Research
Co-authored papers 1
Leeds Institute of Medical Research at St James's, University of Leeds
Co-authored papers 1
Ottawa Hospital Research Institute
Co-authored papers 1
University of Ottawa
Co-authored papers 1
Ottawa Hospital Research Institute, The Ottawa Hospital
Co-authored papers 1